Ari Melnick

55.0k total citations · 8 hit papers
355 papers, 23.9k citations indexed

About

Ari Melnick is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Ari Melnick has authored 355 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 250 papers in Molecular Biology, 106 papers in Hematology and 77 papers in Immunology. Recurrent topics in Ari Melnick's work include Epigenetics and DNA Methylation (111 papers), Acute Myeloid Leukemia Research (82 papers) and Lymphoma Diagnosis and Treatment (63 papers). Ari Melnick is often cited by papers focused on Epigenetics and DNA Methylation (111 papers), Acute Myeloid Leukemia Research (82 papers) and Lymphoma Diagnosis and Treatment (63 papers). Ari Melnick collaborates with scholars based in United States, Canada and Germany. Ari Melnick's co-authors include Jonathan D. Licht, María E. Figueroa, Christopher E. Mason, Francine E. Garrett-Bakelman, José M. Polo, Leandro Cerchietti, Rita Shaknovich, Sheng Li, Matthías Kormáksson and Katerina Hatzi and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Ari Melnick

339 papers receiving 23.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH mutation impairs histone demethylation and results in a block to cell differentiation

2012 1.5k citations Patrick S. Ward, María E. Figueroa et al. profile →
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles

2012 1.4k citations Sheng Li, Francine E. Garrett-Bakelman et al. profile →
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

2017 932 citations Francine E. Garrett-Bakelman, Ari Melnick et al. profile →
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells

2010 893 citations José M. Polo, María E. Figueroa et al. profile →
Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

1999 821 citations Ari Melnick, Jonathan D. Licht Blood profile →
A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells

2012 626 citations José M. Polo, María E. Figueroa et al. profile →
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

2010 578 citations María E. Figueroa, Yushan Li et al. profile →
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

2012 577 citations María E. Figueroa, Aparna Vasanthakumar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ari Melnick United States	84	16.7k	4.8k	4.1k	3.9k	3.8k	355	23.9k
Andrew L. Kung United States	81	16.6k 1.0×	4.1k 0.9×	4.6k 1.1×	2.9k 0.7×	6.6k 1.7×	285	24.2k
Jon C. Aster United States	96	20.4k 1.2×	5.2k 1.1×	3.8k 0.9×	5.5k 1.4×	7.9k 2.0×	278	32.0k
Hong Wu United States	89	16.6k 1.0×	2.6k 0.5×	4.5k 1.1×	3.1k 0.8×	7.2k 1.9×	204	26.2k
James E. Bradner United States	86	24.1k 1.4×	5.8k 1.2×	2.3k 0.6×	1.8k 0.5×	6.3k 1.6×	217	28.8k
Gideon Rechavi Israel	80	18.6k 1.1×	2.1k 0.4×	6.0k 1.4×	2.8k 0.7×	3.7k 1.0×	405	27.0k
Adolfo A. Ferrando United States	65	15.8k 0.9×	4.4k 0.9×	8.6k 2.1×	2.9k 0.8×	3.8k 1.0×	164	23.7k
C Peschle Italy	75	13.2k 0.8×	4.5k 0.9×	5.3k 1.3×	3.8k 1.0×	6.1k 1.6×	321	22.7k
Daniel Birnbaum France	93	17.3k 1.0×	4.0k 0.8×	7.5k 1.8×	4.0k 1.0×	12.8k 3.3×	558	31.8k
Tannishtha Reya United States	38	13.8k 0.8×	2.5k 0.5×	3.7k 0.9×	2.3k 0.6×	7.5k 1.9×	67	21.0k
Toshio Kitamura Japan	76	10.2k 0.6×	3.7k 0.8×	2.0k 0.5×	9.4k 2.4×	5.1k 1.3×	349	23.3k

Countries citing papers authored by Ari Melnick

Since Specialization

Citations

This map shows the geographic impact of Ari Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Melnick more than expected).

Fields of papers citing papers by Ari Melnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ari Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Melnick. The network helps show where Ari Melnick may publish in the future.

Co-authorship network of co-authors of Ari Melnick

This figure shows the co-authorship network connecting the top 25 collaborators of Ari Melnick. A scholar is included among the top collaborators of Ari Melnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ari Melnick. Ari Melnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Isshiki, Yusuke, Patrizia Porazzi, Ari Melnick, Marco Ruella, & Wendy Béguelin. (2023). EZH2 INHIBITION ENHANCES CAR T ANTITUMOR EFFECT BY INDUCING LYMPHOMA IMMUNOGENICITY AND ENHANCING T CELL FUNCTION. Hematological Oncology. 41(S2). 228–228.

Li, Meng, Matthew Teater, Jun Young Hong, et al.. (2021). Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival. Blood Cancer Discovery. 3(1). 50–65. 18 indexed citations

Li, Sheng, Jiahui Wang, Cem Meydan, et al.. (2020). Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML. Cancer Discovery. 10(12). 1934–1949. 24 indexed citations

Fernando, Tharu M., Rossella Marullo, Jude M. Phillip, et al.. (2019). BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress. Cancer Discovery. 9(5). 662–679. 31 indexed citations

Shih, Alan H., Cem Meydan, Kaitlyn Shank, et al.. (2017). Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia. Cancer Discovery. 7(5). 494–505. 71 indexed citations

Saba, Nakhle S., Deanna H. Wong, Patricia Lobelle‐Rich, et al.. (2017). MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. Cancer Research. 77(24). 7038–7048. 40 indexed citations

Fiskus, Warren, Veena Coothankandaswamy, Jianguang Chen, et al.. (2016). SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents. Cancer Research. 76(18). 5467–5478. 57 indexed citations

Meyer, Sara E., Tingting Qin, David E. Muench, et al.. (2016). DNMT3A Haploinsufficiency Transforms FLT3 ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia. Cancer Discovery. 6(5). 501–515. 70 indexed citations

Du, Wei, Rebecca Goldstein, Yanwen Jiang, et al.. (2014). A Virtual B Cell Lymphoma Model to Predict Effective Combination Therapy. Blood. 124(21). 928–928. 1 indexed citations

10.

Fiskus, Warren, Nakhle S. Saba, Min Shen, et al.. (2014). Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia. Cancer Research. 74(9). 2520–2532. 198 indexed citations

11.

Nayar, Utthara, Pin Lü, Rebecca Goldstein, et al.. (2013). Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood. 122(16). 2837–2847. 54 indexed citations

12.

Lin, Pei‐Chun, Ya‐Lin Chiu, Samprit Banerjee, et al.. (2012). Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression. Cancer Research. 73(3). 1232–1244. 144 indexed citations

13.

Nischal, Sangeeta, Sanchari Bhattacharyya, Maximilian Christopeit, et al.. (2012). Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms. Cancer Research. 73(3). 1076–1085. 42 indexed citations

14.

Shah, Mrinal Y., Aparna Vasanthakumar, Natalie Y. Barnes, et al.. (2010). DNMT3B7, a Truncated DNMT3B Isoform Expressed in Human Tumors, Disrupts Embryonic Development and Accelerates Lymphomagenesis. Cancer Research. 70(14). 5840–5850. 52 indexed citations

15.

Figueroa, María E., Lucy Skrabanek, Yushan Li, et al.. (2009). MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood. 114(16). 3448–3458. 231 indexed citations

16.

Martin, Peter, Amy Chadburn, Paul J. Christos, et al.. (2009). Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma. Journal of Clinical Oncology. 27(8). 1209–1213. 234 indexed citations

17.

Lopes, Eloisi Caldas, Ester Valls, María E. Figueroa, et al.. (2008). Kaiso Contributes to DNA Methylation-Dependent Silencing of Tumor Suppressor Genes in Colon Cancer Cell Lines. Cancer Research. 68(18). 7258–7263. 86 indexed citations

18.

Cerchietti, Leandro, José M. Polo, Gustavo Felippe da Silva, et al.. (2008). Sequential Transcription Factor Targeting for Diffuse Large B-Cell Lymphomas. Cancer Research. 68(9). 3361–3369. 25 indexed citations

19.

Laurenzana, Anna, Luca A. Petruccelli, Filippa Pettersson, et al.. (2008). Inhibition of DNA Methyltransferase Activates Tumor Necrosis Factor α–Induced Monocytic Differentiation in Acute Myeloid Leukemia Cells. Cancer Research. 69(1). 55–64. 24 indexed citations

20.

Parekh, Samir, José M. Polo, Rita Shaknovich, et al.. (2007). BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood. 110(6). 2067–2074. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact